REBETRON^TM Combination Therapy
REBETOL® (Ribavirin, USP) Capsules
INTRON® A (Interferon alfa-2b, recombinant) Injection

REBETRON^TM Combination Therapy is indicated by the Food and Drug Administration for the treatment of chronic hepatitis C in patients with compensated liver disease who have relapsed following alfa interferon therapy.

Prior to the availability of REBETRON^TM Combination Therapy, the only drugs approved in the United States for treating hepatitis C had been alfa interferons.